CBA
ITCI icon

Coastal Bridge Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Coastal Bridge Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-21,605
Closed -$161K – 155
2019
Q3 		$161K Hold
21,605
– – 0.06% 139
2019
Q2 		$280K Hold
21,605
– – 0.08% 96
2019
Q1 		$263K Buy
+21,605
New +$276K 0.09% 99

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Coastal Bridge Advisors's ITCI Position: Q4 2019 in Review

Coastal Bridge Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2019, closing a stake of 21,605 shares — an estimated $161K sold.

Coastal Bridge Advisors first reported a position in ITCI in Q1 2019 and held it in 3 quarters. The position peaked at $280K in Q2 2019. 133 funds tracked by Wall St. Rank hold ITCI as of Q4 2019.

  • Coastal Bridge Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2019 after selling out during the quarter.
  • Coastal Bridge Advisors sold 21,605 Intra-Cellular Therapies Inc. shares in Q4 2019, an estimated $161K.
  • Coastal Bridge Advisors first reported a position in Intra-Cellular Therapies Inc. in Q1 2019 and held it in 3 quarters.
  • Coastal Bridge Advisors's Intra-Cellular Therapies Inc. position peaked at $280K in Q2 2019.
  • 133 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2019.

Based on Coastal Bridge Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.